Karyopharm Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KPTI and other ETFs, options, and stocks.About KPTI
Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A.
KPTI Key Statistics
Stock Snapshot
As of today, Karyopharm Therapeutics(KPTI) shares are valued at $5.13. The company's market cap stands at 95.66M, with a P/E ratio of -0.33.
As of 2026-03-25, Karyopharm Therapeutics(KPTI) stock has fluctuated between $5.10 and $5.71. The current price stands at $5.13, placing the stock +0.6% above today's low and -10.2% off the high.
Karyopharm Therapeutics(KPTI) shares are trading with a volume of 1.65M, against a daily average of 2.49M.
During the past year, Karyopharm Therapeutics(KPTI) stock moved between $3.51 at its lowest and $10.99 at its peak.
During the past year, Karyopharm Therapeutics(KPTI) stock moved between $3.51 at its lowest and $10.99 at its peak.
KPTI News
Assertio (ASRT) shares ended the last trading session 17.9% higher at $16.51. The jump came on an impressive volume with a higher-than-average number of shares...
Karyopharm Therapeutics ( (KPTI) ) has provided an update. On March 24, 2026, Karyopharm announced a $30 million private placement with RA Capital Management,...
Analyst ratings
88%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.